You are viewing the "Sydney Lupkin | NPR" Archives
Health policy researchers say Trump may not be able to pay for the cards, which fall short of lasting policy changes to curb high drug prices.
If the company’s vaccine candidate pans out, Americans can receive it for free, under the deal. The arrangement is part of the U.S. government’s push to have a vaccine widely available by January.
Companies that made hats, socks and teddy bears have started producing surgical masks to protect people from COVID-19. Some sellers exaggerate their standing with the Food and Drug Administration.
On Friday, the Food and Drug Administration authorized emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences’ lobbying hit a new high in the first quarter.